Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Compounds such as GHK-Cu have been developed to explore signalling pathways and peptide interactions in controlled laboratory environments
Between late 2023 and 2024, the FDA moved several popular peptides to the Category 2 list, citing concerns about insufficient human safety data and the potential for immunogenicity (the property of provoking an immune response)
Ether-linked diglycerides are non-hydrolyzable, leading to sustained signaling events, whereas ester-linked DAGs are rapidly metabolized [1]
Two carriers to deliver them
US$ 29.27
US$ 29.97
US$ 28.66
US$ 25.94
US$ 23.49
US$ 21.83
US$ 21.30
US$ 28.34
